share_log

和鉑醫藥-B：股東週年大會適用的代表委任表格

HBM HOLDINGS-B: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 24 19:27
Summary by Moomoo AI
和鉑醫藥-B（02142.HK）將於2024年6月6日在中國上海自由貿易試驗區舉行股東週年大會。會議將討論包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表、董事會報告與核數師報告在內的多項議程。此外，會上將進行董事選舉，包括王勁松博士、戎一平博士和Albert R. Collinson博士的重選，並將討論授權董事會釐定董事酬金、續聘安永會計師事務所為核數師及其酬金的決議。股東亦將授予董事發行及購回股份的一般授權。股東可委任代表出席大會並投票，代表委任表格需於2024年6月4日前遞交。
和鉑醫藥-B（02142.HK）將於2024年6月6日在中國上海自由貿易試驗區舉行股東週年大會。會議將討論包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表、董事會報告與核數師報告在內的多項議程。此外，會上將進行董事選舉，包括王勁松博士、戎一平博士和Albert R. Collinson博士的重選，並將討論授權董事會釐定董事酬金、續聘安永會計師事務所為核數師及其酬金的決議。股東亦將授予董事發行及購回股份的一般授權。股東可委任代表出席大會並投票，代表委任表格需於2024年6月4日前遞交。
AND PLATINUM PHARMACEUTICAL-B (02142.HK) WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 6, 2024 IN SHANGHAI, CHINA'S EXPERIMENTAL FREE TRADE ZONE. The meeting will discuss a number of agendas including the review and adoption of the Audited Consolidated Financial Statements, Board Reports and Auditor's Reports for the year ended 31 December 2023. In addition, the Board will hold the election of directors, including the re-election of Dr. Wang Jinsong, Dr. Jung Yiping and Dr. Albert R. Collinson, and the resolution to authorize the Board of Directors to determine the remuneration of directors, the renewal of EY Accounting Firm as auditor and its remuneration will be discussed. Shareholders will also grant the Director a general mandate to issue and repurchase shares. Shareholders may appoint representatives to attend the general meeting and vote. The proxy form must be submitted by 4 June 2024.
AND PLATINUM PHARMACEUTICAL-B (02142.HK) WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 6, 2024 IN SHANGHAI, CHINA'S EXPERIMENTAL FREE TRADE ZONE. The meeting will discuss a number of agendas including the review and adoption of the Audited Consolidated Financial Statements, Board Reports and Auditor's Reports for the year ended 31 December 2023. In addition, the Board will hold the election of directors, including the re-election of Dr. Wang Jinsong, Dr. Jung Yiping and Dr. Albert R. Collinson, and the resolution to authorize the Board of Directors to determine the remuneration of directors, the renewal of EY Accounting Firm as auditor and its remuneration will be discussed. Shareholders will also grant the Director a general mandate to issue and repurchase shares. Shareholders may appoint representatives to attend the general meeting and vote. The proxy form must be submitted by 4 June 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more